(August 4, 2020, 8:59 AM EDT) -- SAN FRANCISCO — Following the U.S. Supreme Court's precedent in another California state court drug case, a California appeals court panel on July 30 ruled that a state court does not have personal jurisdiction over nonresident drug companies in hundreds of cases by out-of-state plaintiffs alleging injuries from off-label marketing of the heart arrythmia drug amiodarone (In re Amiodarone Cases, Nos. A157035, A158160 and A159522, Calif. App., 1st Dist., Div. 2, 2020 Cal. App. Unpub. LEXIS 4874)....